Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
CASH FLOW FROM OPERATING ACTIVITIES
Net income	$ 3,078	$ 4,696	$ 13,304
Adjustments to reconcile net income to net cash from operating activities:
Discontinued operations, net	(182)	0	0
Depreciation, depletion and amortization of assets	7,371	6,865	6,926
Deferred income tax provision (benefit)	(461)	57	(1,644)
Other noncash charges (benefit) to income	543	(100)	(8)
Asset impairments and related items	1,281	209	0
Losses (gains) on sales of assets and other, net	60	(522)	(308)
Undistributed losses (earnings) from equity investments	(79)	144	(219)
Dry hole expense	106	299	84
Changes in operating assets and liabilities:
(Increase) decrease in trade receivables	(133)	1,088	(97)
Increase in inventories	(46)	(91)	(230)
(Increase) decrease in joint interest receivables and other current assets	303	(13)	(335)
Decrease in accounts payable and accrued liabilities	(661)	(549)	(478)
Increase (decrease) in current domestic and foreign income taxes	559	225	(185)
Operating cash flow from continuing operations	11,739	12,308	16,810
Operating cash flow from discontinued operations	(300)	0	0
Net cash provided by operating activities	11,439	12,308	16,810
CASH FLOW FROM INVESTING ACTIVITIES
Capital expenditures	(7,018)	(6,270)	(4,497)
Change in capital accrual	96	25	147
Purchases of assets, businesses and equity investments, net	(9,129)	(713)	(990)
Proceeds from sale of assets and equity investments, net	1,673	448	584
Equity investments and other, net	(212)	(470)	(116)
Net cash used by investing activities	(14,590)	(6,980)	(4,872)
CASH FLOW FROM FINANCING ACTIVITIES
Draws on receivables securitization facility	0	900	400
Payment of receivables securitization facility	0	(900)	(400)
Proceeds from long-term debt, net	9,612	(46)	0
Payments of long-term debt, net	(4,514)	(22)	(9,484)
Redemption of preferred stock	0	(1,661)	0
Purchases of treasury stock	(27)	(1,798)	(3,099)
Cash dividends paid on common and preferred stock	(1,446)	(1,365)	(1,184)
Proceeds from issuance of common stock	584	135	293
Contributions from noncontrolling interest	200	100	0
Financing portion of net cash paid for derivative instruments	0	0	(111)
Deferred payments for purchases of assets and businesses	(318)	0	0
Other financing, net	(247)	(233)	(130)
Net cash provided (used) by financing activities	3,844	(4,890)	(13,715)
Increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	693	438	(1,777)
Cash, cash equivalents, restricted cash and restricted cash equivalents — beginning of year	1,464	1,026	2,803
Cash, cash equivalents, restricted cash and restricted cash equivalents — end of year	$ 2,157	$ 1,464	$ 1,026